Haploinsufficiency of insulin gene enhancer protein 1 (Isl1) is associated with d-transposition of the great arteries

Molecular Genetics and Genomic Medicine

Volumn 2, Issue 4, 2014, Pages 341-351

  Osoegawa, Kazutoyo ^a,b   Schultz, Kathleen ^a   Yun, Kenneth ^a   Mohammed, Nebil ^a   Shaw, Gary M ^b   Lammer, Edward J ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conotruncal defects; Haploinsufficiency; ISL1; Microdeletion

Indexed keywords

EID: 84928763928     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.75     Document Type: Article

References (32)

1. Adzhubei, I. A., S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova, P. Bork, et al. 2010. A method and server for predicting damaging missense mutations. Nat. Methods 7:248–249.
2. Bansal, V., C. Dorn, M. Grunert, S. Klaassen, R. Hetzer, F. Berger, et al. 2014. Outlier-based identification of copy number variations using targeted resequencing in a small cohort of patients with tetralogy of fallot. PLoS ONE 9: e85375.
3. Bromberg, Y., and B. Rost. 2007. Snap: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 35:3823–3835.
4. Bunyan, D. J., D. M. Eccles, J. Sillibourne, E. Wilkins, N. S. Thomas, J. Shea-Simonds, et al. 2004. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br. J. Cancer 91:1155–1159.
5. Cai, C. L., X. Liang, Y. Shi, P. H. Chu, S. L. Pfaff, J. Chen, et al. 2003. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5:877–889.
6. Choi, Y., G. E. Sims, S. Murphy, J. R. Miller, and A. P. Chan. 2012. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7:e46688.
7. Ferencz, C., J. D. Rubin, R. J. McCarter, J. I. Brenner, C. A. Neill, L. W. Perry, et al. 1985. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington infant study. Am. J. Epidemiol. 121:31–36.
8. Firth, H. V., S. M. Richards, A. P. Bevan, S. Clayton, M. Corpas, D. Rajan, et al. 2009. Decipher: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am. J. Hum. Genet. 84:524–533.
9. Friedrich, F. W., G. Dilanian, P. Khattar, D. Juhr, L. Gueneau, P. Charron, et al. 2013. A novel genetic variant in the transcription factor islet-1 exerts gain of function on myocyte enhancer factor 2c promoter activity. Eur. J. Heart Fail. 15:267–276.
10. Golzio, C., E. Havis, P. Daubas, G. Nuel, C. Babarit, A. Munnich, et al. 2012. Isl1 directly regulates fgf10 transcription during human cardiac outflow formation. PLoS ONE 7:e30677.
11. Hoffman, J. I., and S. Kaplan. 2002. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39:1890–1900.
12. Jenkins, K. J., A. Correa, J. A. Feinstein, L. Botto, A. E. Britt, S. R. Daniels, et al. 2007. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the american heart association council on cardiovascular disease in the young: endorsed by the american academy of pediatrics. Circulation 115:2995–3014.
13. Kent, W. J. 2002. Blat–the blast-like alignment tool. Genome Res. 12:656–664.
14. Kodo, K., T. Nishizawa, M. Furutani, S. Arai, K. Ishihara, M. Oda, et al. 2012. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects. Circ. J. 76:1703–1711.
15. Koolen, D. A., W. M. Nillesen, M. H. Versteeg, G. F. Merkx, N. V. Knoers, M. Kets, et al. 2004. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (mlpa). J. Med. Genet. 41:892–899.
16. Kumar, P., S. Henikoff, and P. C. Ng. 2009. Predicting the effects of coding non-synonymous variants on protein function using the sift algorithm. Nat. Protoc. 4:1073–1081.
17. Lammer, E. J., J. S. Chak, D. M. Iovannisci, K. Schultz, K. Osoegawa, W. Yang, et al. 2009. Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res. 85:30–35.
18. Macdonald, J. R., R. Ziman, R. K. Yuen, L. Feuk, and S. W. Scherer. 2014. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 42:D986–D992.
19. Malcoe, L. H., G. M. Shaw, E. J. Lammer, and A. A. Herman. 1999. The effect of congenital anomalies on mortality risk in white and black infants. Am. J. Public Health 89:887–892.
20. Moretti, A., L. Caron, A. Nakano, J. T. Lam, A. Bernshausen, Y. Chen, et al. 2006. Multipotent embryonic isl1 + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151–1165.
21. O’Malley, C. D., G. M. Shaw, C. R. Wasserman, and E. J. Lammer. 1996. Epidemiologic characteristics of conotruncal heart defects in california, 1987–1988. Teratology 53:374–377.
22. Osoegawa, K., G. M. Vessere, K. H. Utami, M. A. Mansilla, M. K. Johnson, B. M. Riley, et al. 2008. Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J. Med. Genet. 45:81–86.
23. Osoegawa, K., D. M. Iovannisci, B. Lin, C. Parodi, K. Schultz, G. M. Shaw, et al. 2014. Identification of novel candidate gene loci and increased sex chromosome aneuploidy among infants with conotruncal heart defects. Am. J. Med. Genet. 164:397–406.
24. Pastwa, E., and J. Blasiak. 2003. Non-homologous DNA end joining. Acta Biochim. Pol. 50:891–908.
25. Rozen, S., and H. Skaletsky. 2000. Primer3 on the www for general users and for biologist programmers. Methods Mol. Biol. 132:365–386.
26. Schouten, J. P., C. J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30:e57.
27. Shaw, G. M., S. L. Carmichael, W. Yang, and E. J. Lammer. 2010. Periconceptional nutrient intakes and risks of conotruncal heart defects. Birth Defects Res. 88:144–151.
28. Stevens, K. N., H. Hakonarson, C. E. Kim, P. A. Doevendans, B. P. Koeleman, S. Mital, et al. 2010. Common variation in isl1 confers genetic susceptibility for human congenital heart disease. PLoS ONE 5:e10855.
29. Tanizawa, Y., A. C. Riggs, S. Dagogo-Jack, M. Vaxillaire, P. Froguel, L. Liu, et al. 1994. Isolation of the human lim/ homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected]. Diabetes 43:935– 941.
30. Vissers, L. E., C. M. van Ravenswaaij, R. Admiraal, J. A. Hurst, B. B. de Vries, I. M. Janssen, et al. 2004. Mutations in a new member of the chromodomain gene family cause charge syndrome. Nat. Genet. 36:955–957.
31. Yau, S. C., M. Bobrow, C. G. Mathew, and S. J. Abbs. 1996. Accurate diagnosis of carriers of deletions and duplications in duchenne/becker muscular dystrophy by fluorescent dosage analysis. J. Med. Genet. 33:550–558.
32. Zhi, J. 2010. Mapd: a probe design suite for multiplex ligation-dependent probe amplification assays. BMC Res. Notes 3:137.